Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/asco21-bristol-myers-solo-dual-i-o-regimens-best-chemo-alone-with-one-exception-in-first-line-esophageal-patients/
https://endpts.com/as-companies-dump-money-into-manufacturing-where-will-they-find-the-trained-workers-to-man-the-lines/
https://www.fiercepharma.com/marketing/j-j-nabs-fda-nod-for-ponvory-joining-novartis-bristol-myers-and-others-crowded-ms-market
https://endpts.com/another-keytruda-combo-tops-standard-of-care-in-advanced-kidney-cancer-posing-another-test-for-bristols-i-o-meds/
https://www.fiercepharma.com/marketing/asco-gu-2-year-data-jury-s-still-out-kidney-cancer-race-between-opdivo-cabometyx-and
https://www.pharmtech.com/view/fda-approves-bristol-myers-squibb-s-car-t-cell-therapy-lymphoma-treatment
https://www.fiercepharma.com/pharma/bms-can-grow-through-revlimid-generics-execs-insist-pointing-to-key-launches
https://www.fiercebiotech.com/biotech/chutes-ladders-bristol-myers-hematology-chief-ahmed-hits-exit
https://www.fiercepharma.com/pharma-asia/pd-1-l1-drugmakers-merck-bristol-myers-astrazeneca-and-roche-lose-bid-to-expand-reach